Stay updated on Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial page.

Latest updates to the Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedSponsor-related navigation text and links referencing Bayer were removed from the study page.SummaryDifference0.2%

- Check28 days agoChange DetectedRevision tag changed from v3.4.1 to v3.4.2 with no visible content or functional changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision: v3.4.1 was added and the prior government operating-status notices were removed; this is a routine site update that does not affect the study details or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedA site-wide notice about a lapse in government funding appears at the top of the page, indicating that information may not be up to date and that some transactions may not be processed, with details and status updates linked to cc.nih.gov and opm.gov. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check49 days agoChange DetectedGlossary display is now always visible and new metadata entries (Last Update Submitted that Met QC Criteria) and a Revision: v3.4.0 were added, with minor capitalization tweaks. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial page.